First Trust Nasdaq Pharmaceuticals ETF (FTXH)

FTXH Holdings Information

FTXH is an equity ETF with a total of 49 individual holdings. The top holdings are Johnson & Johnson stock at 7.92%, AbbVie at 7.72%, Pfizer at 6.89%, Merck & Co. at 6.77%, and Bristol-Myers Squibb Company at 5.84%.

• Total Holdings: 49
• Top 10 Percentage: 54.84%
• Asset Class: Equity
• ETF Category: Health
• Assets: 15.68M
• PE Ratio: 15.68

Top 25 Holdings

As of Sep 11, 2025

Filter results

No.	Symbol	Name	% Weight	Shares
1	JNJ	Johnson & Johnson	7.92%	6,956
2	ABBV	AbbVie Inc.	7.72%	5,494
3	PFE	Pfizer Inc.	6.89%	43,450
4	MRK	Merck & Co., Inc.	6.77%	12,449
5	BMY	Bristol-Myers Squibb Company	5.84%	19,265
6	UTHR	United Therapeutics Corporation	4.64%	1,795
7	VTRS	Viatris Inc.	4.04%	62,238
8	BIIB	Biogen Inc.	3.88%	4,089
9	GILD	Gilead Sciences, Inc.	3.78%	5,025
10	AMGN	Amgen Inc.	3.35%	1,859
11	ZTS	Zoetis Inc.	3.29%	3,424
12	JAZZ	Jazz Pharmaceuticals plc	3.27%	3,989
13	LLY	Eli Lilly and Company	3.00%	622
14	REGN	Regeneron Pharmaceuticals, Inc.	2.97%	819
15	ELAN	Elanco Animal Health Incorporated	2.81%	23,419
16	MEDP	Medpace Holdings, Inc.	2.76%	870
17	CRL	Charles River Laboratories International, Inc.	2.03%	1,987
18	EXEL	Exelixis, Inc.	1.95%	7,821
19	ILMN	Illumina, Inc.	1.90%	2,996
20	OGN	Organon & Co.	1.89%	27,775
21	HALO	Halozyme Therapeutics, Inc.	1.80%	3,636
22	NBIX	Neurocrine Biosciences, Inc.	1.66%	1,811
23	BMRN	BioMarin Pharmaceutical Inc.	1.00%	2,815
24	AMRX	Amneal Pharmaceuticals, Inc.	0.98%	15,230
25	ALNY	Alnylam Pharmaceuticals, Inc.	0.96%	320

Showing 25 of 49 holdings

Subscribe to see the full list